SCHEMBL7877970

SCHEMBL7877970

COC(=O)c1cc2c(C)cccc2n1C

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 1/20 0.59
L3MBTL1 Q9Y468 1/20 0.54
KDM4E B2RXH2 2/20 0.53
ALKBH5 Q6P6C2 1/20 0.44
FTO Q9C0B1 1/20 0.44
MAPT P10636 3/20 0.43
HPGD P15428 2/20 0.43
TSHR P16473 1/20 0.43
PABPC1 P11940 1/20 0.43
EIF4H Q15056 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HSD17B10 Q99714 1/20 0.43
NR4A2 P43354 2/20 0.42
LMNA P02545 2/20 0.41
TP53 P04637 1/20 0.41
MCL1 Q07820 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
SRC P12931 2/20 0.41
EGFR P00533 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2276664 0.83 L3MBTL1 (0.52) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL7884466 0.83 KDM4E (0.51) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL3561006 0.83 KDM4E (0.51) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL2326493 0.83 KDM4E (0.51) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL2276306 0.82 SLC9A1 (0.64) SLC9A1KDM4EALKBH5FTOMAPT
SCHEMBL2275127 0.81 SLC9A1 (0.59) SLC9A1KDM4EALKBH5FTOMAPT
SCHEMBL19331188 0.79 L3MBTL1 (0.51) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL4486403 0.79 L3MBTL1 (0.67) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL29834903 0.79 L3MBTL1 (0.67) SLC9A1L3MBTL1KDM4EMAPTHPGD
SCHEMBL7880056 0.78 L3MBTL1 (0.50) L3MBTL1KDM4EMAPTHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1067988-C Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 2001-07-04 CN disclosed
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
CN-1051301-C Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 2000-04-12 CN disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
CN-1136038-A Indoloylguanidine derivatives SUMITOMO PHARMACEUTICS K K (JP) 1996-11-20 CN disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
CN-1106800-A Indoloylguanidine derivatives SUMITOMO PHARMA (JP) 1995-08-16 CN disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed